Tool · Post-Market Surveillance

PSUR Report

The vigilance database section of your PSUR, generated in seconds: FDA MAUDE adverse event trends, recalls, and enforcement classifications for your device and similar devices — with the documented, reproducible methodology auditors ask for.

Period
from
to
Leave empty for the last 24 months

Reporting period 2024-072026-06 · FDA data refreshed ~monthly

Product Code: HCG FDA class 2

Device, Neurovascular Embolization

View full classification →
Adverse events in period
1,014
-12% vs. prior period (1,156)
Deaths reported
15
Recalls in period
3
Class I enforcement
1

Adverse events per month

2024-07 – 2026-06
Loading...

Events by type

Period vs. prior period
Loading...
Event type
Period
Prior
Death
15
23
Injury
215
244
Malfunction
784
889

Most reported coded problems

Top 15
Product problems
Count
Premature Separation
589
Physical Resistance/Sticking
146
Fracture
126
Adverse Event Without Identified Device or Use Problem
100
Migration
92
Stretched
46
Unraveled Material
31
Difficult or Delayed Separation
29
Expulsion
20
Material Deformation
19
Separation Problem
15
Detachment of Device or Device Component
13
Separation Failure
11
Failure to Advance
10
Failure to Fold
8
Patient problems
Count
No Clinical Signs, Symptoms or Conditions
834
Foreign Body In Patient
43
Aneurysm
22
Thrombosis/Thrombus
18
Ruptured Aneurysm
17
Intracranial Hemorrhage
14
Insufficient Information
14
Stroke/CVA
11
Hemorrhage/Blood Loss/Bleeding
11
Device Embedded In Tissue or Plaque
11
Obstruction/Occlusion
8
Ischemia Stroke
8
Ischemia
8
Vasoconstriction
6
Paralysis
6

Recalls in period

3 total
FDA enforcement classification: Class I: 1 Class II: 2
Date
Recalling firm
Status
2026-04-06
Open, Classified
2025-10-02
Open, Classified
2025-05-08
Open, Classified

Adverse events by year

Loading...

Methodology & data provenance

For your PSUR appendix

Search protocol: FDA MAUDE adverse event reports, FDA device recalls, and FDA enforcement reports (openFDA datasets) were queried for product code HCG, reporting period 2024-07 to 2026-06 (prior comparison period 2022-07 to 2024-06).

Data coverage: adverse event data for these product codes extends through 2026-05. Source openFDA export dated 2026-06-30. Recall records with missing or implausible initiation dates (0 for these codes) are excluded from period counts.

Generated: 2026-07-05 21:22 UTC by BEUDAMED (beudamed.com/fda/psur-report). Dataset sizes: 25,039,198 adverse events, 58,607 recalls, 39,365 enforcement reports.

PSUR database searches, explained

Under the EU MDR, manufacturers must produce a Periodic Safety Update Report (PSUR) (Class IIa and above; a PMS report for Class I) on a defined schedule. A required part of that report is a survey of publicly available vigilance data — most importantly the FDA's MAUDE adverse event database and FDA recall records — covering both your own device and similar devices on the market (the "state of the art").

Doing this by hand means repeated MAUDE queries, manual export, deduplication, and trending — hours of work per report, repeated every reporting period. This tool runs the same search protocol in seconds and documents it: which datasets were queried, with which filters, when, and with what coverage — so the search is reproducible, which is exactly what a Notified Body auditor wants to see.

Event counts are grouped by the FDA's reported event type (death, injury, malfunction). Name-based device matching is clearly labeled as indicative: only you can confirm whether a specific MAUDE report concerns your device. Recall records with implausible dates are excluded and the exclusion is disclosed. All data is from the official openFDA datasets and refreshed approximately monthly.